Wednesday, September 22, 2021


India posts most Covid cases in 2 months

Densely populated Kerala, on India's southern tip, accounted for nearly 70% of the 47,092 new infections and a third of deaths, a week after it celebrated its biggest festival.

Clot risk far lower from vaccines than virus, UK study shows

It says increased risks associated with the jabs are short-term only, while virus infection is associated with increased risk for the whole of the 28-day period examined.

Vaccine protection wanes within 6 months, says phone app study

The Pfizer jab fell in effectiveness to 74% after five to six months while the AstraZeneca vaccine fell to 67% after four to five months.

AstraZeneca hails trial results for Covid treatment

It is hoped that the drug could be used alongside vaccines for those who need more protection, affording up to 12 months of defence.

Pfizer Covid jab declines faster than AstraZeneca, study shows

Two doses of Pfizer have greater initial effectiveness against new Covid-19 infections, but this declines faster compared with two doses of AstraZeneca, Oxford researchers say.

AstraZeneca boss tops CEO pay chart in UK, survey shows

AstraZeneca chief executive Pascal Soriot managed to earn the equivalent of US$21.25 million or 50% more than his nearest challenger.

AstraZeneca says Covid vaccine sales top US$1 billion

The group shipped about 319 million doses worldwide during the first half of the year, which included US$572 million of sales in Europe and US$455 million in emerging markets.

AstraZeneca searching for vaccines for virus-hit Southeast Asia

'A global supply crunch' for Covid-19 vaccines and a shortage of the materials required to make them makes it difficult to provide a specific timeframe, the drugmaker's representative in Thailand says.

Pemberhentian Sinovac tiada kaitan soal keberkesanan, kata KJ

Beliau berkata Pharmaniaga Bhd selesai membekalkan 12 juta dos vaksin keluaran China itu lebih awal daripada jadual asal kepada kerajaan.

EU says no problem with WHO-approved vaccines

EU ambassador to Malaysia says recent reports on the origin of AstraZeneca vaccines are inaccurate.

No reason for EU to discriminate over AstraZeneca jabs, Khairy says again

He says he will discuss the matter with the EU ambassador to Malaysia to clarify the immigration policy with regards to vaccination.

Vaccines the same no matter point of origin, says Khairy

The minister in charge of vaccine procurement says there should be no discrimination over where vaccines are made as the same formula is used at all manufacturing plants.

Other News